Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Study of Adjuvant Radiotherapy With Versus Without Concurrent Goserelin in Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer

NCT00423475 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT00423475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00423475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Study of Adjuvant Radiotherapy With Versus Without Concurrent Goserelin in Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2006
Completion date
Not reported
Enrollment
743 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer